标题
MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
作者
关键词
-
出版物
Cancer Cell International
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-04-15
DOI
10.1186/s12935-021-01873-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2
- (2019) Ying Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A
- (2019) Yi Zhang et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells
- (2019) Di Hu et al. Genetic Testing and Molecular Biomarkers
- miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint
- (2019) Duolu Li et al. EXPERIMENTAL CELL RESEARCH
- MiR-202-5p/PTEN mediates doxorubicin-resistance of breast cancer cells via PI3K/Akt signaling pathway
- (2019) Tao Liu et al. CANCER BIOLOGY & THERAPY
- Role of MAML1 in targeted therapy against the esophageal cancer stem cells
- (2019) Meysam Moghbeli et al. Journal of Translational Medicine
- MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway
- (2019) Hong Dai et al. BIOSCIENCE REPORTS
- MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways
- (2019) Cong Liu et al. CELL CYCLE
- circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer
- (2019) Yiran Liang et al. ONCOGENE
- MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer
- (2019) Xiao Lu et al. ONCOGENE
- Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
- (2019) Shu Lin et al. Cell Death & Disease
- Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
- (2019) Zahra Bolandghamat Pour et al. BMC CANCER
- MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer
- (2018) Manxin Xie et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1
- (2018) Dawei Wu et al. CANCER GENE THERAPY
- Cancer stem cell in breast cancer therapeutic resistance
- (2018) Xupeng Bai et al. CANCER TREATMENT REVIEWS
- Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer
- (2018) Liang Chang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer
- (2018) Huaping Xiong et al. CELLULAR SIGNALLING
- Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
- (2018) Ernestina De Francesco et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
- (2018) Yaming Li et al. Cell Death & Disease
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma
- (2018) Mohammad Reza Abbaszadegan et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- miR-381 induces sensitivity of breast cancer cells to doxorubicin by inactivation of MAPK signaling via FYN
- (2018) Hailong Mi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor
- (2018) Deli Hong et al. MOLECULAR CANCER RESEARCH
- FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation
- (2018) Shaoqiang Cheng et al. CANCER BIOLOGY & THERAPY
- The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin
- (2018) Baojuan Han et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway
- (2017) Hongyu Shen et al. GENE
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer
- (2017) Shihua Chu et al. ONCOLOGY REPORTS
- Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection
- (2017) Christina L. Roland et al. SURGERY
- miR-214 promotes apoptosis and sensitizes breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade
- (2016) Jiaxuan Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Extracellular nicotinamide phosphoribosyltransferase, a new cancermetabokine
- (2016) Ambra A Grolla et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long non-coding RNAs in cancer drug resistance development
- (2016) Maryam Majidinia et al. DNA REPAIR
- MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway
- (2016) Hongyu Shen et al. GENE
- MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
- (2016) Lin Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas
- (2016) Aaron Goodman et al. Nature Reviews Clinical Oncology
- MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway
- (2016) Xiaohui Zhang et al. PLoS One
- miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
- (2016) Y Hu et al. Cell Death & Disease
- miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
- (2016) Man Gao et al. Oncotarget
- A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer
- (2016) Do Yeon Kim et al. Oncotarget
- Correlation of Wnt and NOTCH pathways in esophageal squamous cell carcinoma
- (2016) Meysam Moghbeli et al. Journal of Cell Communication and Signaling
- MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1
- (2015) Lin Lu et al. BIOTECHNOLOGY LETTERS
- miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer
- (2015) Yunhui Hu et al. BREAST CANCER RESEARCH AND TREATMENT
- A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G
- (2015) Edgardo D. Carosella et al. EUROPEAN UROLOGY
- Osteopontin in Immune-mediated Diseases
- (2015) S.R. Rittling et al. JOURNAL OF DENTAL RESEARCH
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- miR-181b promotes chemoresistance in breast cancer by regulating Bim expression
- (2015) YABING ZHENG et al. ONCOLOGY REPORTS
- Mechanisms of anterior gradient-2 regulation and function in cancer
- (2015) Veronika Brychtova et al. SEMINARS IN CANCER BIOLOGY
- EMT, CTCs and CSCs in tumor relapse and drug-resistance
- (2015) Abhisek Mitra et al. Oncotarget
- miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1
- (2015) Jingpei Long et al. Biomed Research International
- Role of Msi1 and PYGO2 in esophageal squamous cell carcinoma depth of invasion
- (2015) Meysam Moghbeli et al. Journal of Cell Communication and Signaling
- Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells
- (2015) Y. Fang et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- MiR-133a Is Functionally Involved in Doxorubicin-Resistance in Breast Cancer Cells MCF-7 via Its Regulation of the Expression of Uncoupling Protein 2
- (2015) Yuan Yuan et al. PLoS One
- TALEN-mediated Nanog disruption results in less invasiveness, more chemosensitivity and reversal of EMT in Hela cells
- (2015) Yan Ding et al. Oncotarget
- Breast cancer stem cells, EMT and therapeutic targets
- (2014) Srishti Kotiyal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance
- (2014) E. Y. Park et al. CANCER RESEARCH
- The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy
- (2014) Eilin Austreid et al. EXPERT OPINION ON PHARMACOTHERAPY
- MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway
- (2014) Li Jiang et al. FEBS LETTERS
- Translational control of immune responses: from transcripts to translatomes
- (2014) Ciriaco A Piccirillo et al. NATURE IMMUNOLOGY
- Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cells
- (2014) SUNG UNG MOON et al. ONCOLOGY REPORTS
- Intracellular osteopontin regulates homeostasis and function of natural killer cells
- (2014) Jianmei W. Leavenworth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance
- (2014) Valentina Grossi WORLD JOURNAL OF GASTROENTEROLOGY
- The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin
- (2014) P Geserick et al. Cell Death & Disease
- The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models
- (2014) Amancio Carnero et al. Frontiers in Oncology
- Roles of microRNA-140 in stem cell-associated early stage breast cancer
- (2014) Benjamin Wolfson World Journal of Stem Cells
- Flap Endonuclease 1
- (2013) Lata Balakrishnan et al. Annual Review of Biochemistry
- The Formin Daam1 and Fascin Directly Collaborate to Promote Filopodia Formation
- (2013) Richa Jaiswal et al. CURRENT BIOLOGY
- Emerging role of nanog in tumorigenesis and cancer stem cells
- (2013) Luis E. IV Santaliz-Ruiz et al. INTERNATIONAL JOURNAL OF CANCER
- The Role of MicroRNAs in Breast Cancer Stem Cells
- (2013) Daniela Schwarzenbacher et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
- (2013) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling
- (2013) YONG CHEN et al. Molecular Medicine Reports
- Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition
- (2013) Miler T. Lee et al. NATURE
- The shaping and functional consequences of the microRNA landscape in breast cancer
- (2013) Heidi Dvinge et al. NATURE
- BIM: Enabling Sustainability and Asset Management through Knowledge Management
- (2013) Robbert Anton Kivits et al. TheScientificWorldJOURNAL
- MAWBP and MAWD inhibit proliferation and invasion in gastric cancer
- (2013) Dong-Mei Li WORLD JOURNAL OF GASTROENTEROLOGY
- MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1
- (2012) Xiu-juan Li et al. ARCHIVES OF MEDICAL RESEARCH
- Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
- (2012) D. S. Chen et al. CLINICAL CANCER RESEARCH
- The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development
- (2012) Suman Verma et al. DEVELOPMENTAL BIOLOGY
- Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation
- (2012) Benedikt Gröschl et al. INTERNATIONAL JOURNAL OF CANCER
- α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)
- (2012) Dalila Naci et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration
- (2012) Yichao Zhu et al. PLoS One
- miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression
- (2012) Florian Kopp et al. PLoS One
- MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN
- (2011) Zhao-Xia Wang et al. ARCHIVES OF MEDICAL RESEARCH
- Mechanism of Cell Adaptation
- (2011) Valentina Fodale et al. CANCER JOURNAL
- Chromosomal Instability Confers Intrinsic Multidrug Resistance
- (2011) A. J. X. Lee et al. CANCER RESEARCH
- Protein kinase D: coupling extracellular stimuli to the regulation of cell physiology
- (2011) Ya Fu et al. EMBO REPORTS
- MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating Cells
- (2011) Fengyan Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The expression of Mcl-1 in human cervical cancer and its clinical significance
- (2011) Ting Zhang et al. MEDICAL ONCOLOGY
- MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance
- (2011) Liang Luo et al. MEDICAL ONCOLOGY
- Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer
- (2011) Junqing Chen et al. MEDICAL ONCOLOGY
- The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop
- (2011) A. Menssen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrin β3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer
- (2010) RUI WANG et al. APMIS
- NANOG induction of fetal liver kinase-1 (FLK1) transcription regulates endothelial cell proliferation and angiogenesis
- (2010) E. E. Kohler et al. BLOOD
- Fyn
- (2010) Yoshihito D. Saito et al. CANCER
- Emerging Roles for Natural MicroRNA Sponges
- (2010) Margaret S. Ebert et al. CURRENT BIOLOGY
- Intracellular osteopontin (iOPN) and immunity
- (2010) Makoto Inoue et al. IMMUNOLOGIC RESEARCH
- Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells
- (2010) Fan Lin et al. MOLECULAR BIOLOGY REPORTS
- Multiple Drug Resistance Mechanisms in Cancer
- (2010) Bruce C. Baguley MOLECULAR BIOTECHNOLOGY
- A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth In vitro and In vivo
- (2010) K. B. Harikumar et al. MOLECULAR CANCER THERAPEUTICS
- Functional regulation of FEN1 nuclease and its link to cancer
- (2010) L. Zheng et al. NUCLEIC ACIDS RESEARCH
- miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion
- (2009) Hongping Xia et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrins
- (2009) Malgorzata Barczyk et al. CELL AND TISSUE RESEARCH
- Function and Antagonism of β Integrins in the Development of Cancer Therapy
- (2009) H. Sheldrake et al. CURRENT CANCER DRUG TARGETS
- Histological and molecular types of breast cancer: is there a unifying taxonomy?
- (2009) Britta Weigelt et al. Nature Reviews Clinical Oncology
- Smad, PI3K/Akt, and Wnt-Dependent Signaling Pathways Are Involved in BMP-4-Induced ESC Self-Renewal
- (2009) Min Young Lee et al. STEM CELLS
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2
- (2008) Manav Korpal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
- (2008) Witold Filipowicz et al. NATURE REVIEWS GENETICS
- Modified glutamine catabolism in macrophages of Ucp2 knock-out mice
- (2007) Tobias Nübel et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- The BCL-2 protein family: opposing activities that mediate cell death
- (2007) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started